Regenerative Medicine Market, by Type (Cell-Based Therapy & Cell Immunotherapy Products, Tissue-Engineered Products, Gene Therapy Products); by Applications (Ocular Disorders, Musculoskeletal Disorders, Oncology, Wound Care, Diabetes, Others); and by Region (North America, Europe, Asia Pacific, Latin America, MEA); - Global Forecasts 2021 to 2027

Date : Sep 2021

|

Report ID : 232

|

Category : Healthcare

|
Report Format:  PDF EXCEL PPT WORD

The Global Regenerative Medicine Market Size was valued at USD 19.2 Bn in 2020 and is expected to reach USD 66.4 Bn by 2027, growing at a CAGR of  19.4% during the forecast period.

Regenerative medicine therapies including advanced cell, gene, and tissue therapies that could help to manage and potentially cure many conditions and diseases that are intractable, chronic, and even terminal. However, compared with more mature medical fields that feature a greater number of marketed products and a fully developed infrastructure such as traditional pharmaceutical drugs, medical devices the regenerative medicine field currently has few finalized standards, preventing many novel regenerative medicine therapies from becoming ready for marketing.

The growth of the regenerative medicine market is primarily driven by the increasing prevalence of various chronic diseases such as cancer, CVD, and others across the globe. Major factors behind the burgeoning chronic conditions are unhealthy lifestyle, alcohol consumption, smoking habits, and physical inactiveness. Cancer is the second leading cause of mortality in 2018, with a continuous rise in the number of cancer patients across the globe, as per the report published by WHO. Moreover, as per WHO, nearly one-third of the mortality rate occurs due to cancer. This is due to dietary risk, which includes low fruit and vegetable intake, high body mass index, lack of physical activity, alcohol consumption, and tobacco use.

Tobacco is one of the leading factors for the rise in the prevalence of cancer and moralities that accounted for nearly 22% of the global population. The rising number of cancer patients is the major factor for the growth of the global regenerative medicine market. 

The Global Regenerative Medicine Market Segmentation:

By Type

  • Cell-Based Therapy & Cell Immunotherapy Products
  • Tissue-Engineered Products
  • Gene Therapy Products

By Applications

  • Ocular Disorders
  • Musculoskeletal Disorders
  • Oncology
  • Wound Care
  • Diabetes
  • Others

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Based on type, the cell-based therapy & cell immunotherapy products, is expected to dominate the global regenerative medicine market due to increased investment for research on cell-based immunotherapy & cell therapy

Based on type, the global regenerative medicine market has been segmented into cell-based therapy & cell immunotherapy products, tissue-engineered products, and gene therapy products. The cell-based therapy & cell immunotherapy products segment is projected to witness the fastest market growth during the forecast period. Rising research and investment for cell-based immunotherapies for the treatment of cancer is one of the key driving factors in segmental growth.

Based on application, oncology is expected to dominate the global regenerative medicine market due to increased prevalence of cancer patients

Based on indication, the market has been segmented into musculoskeletal disorders, wound care, oncology, ocular disorders, diabetes, and others application. The oncology segment is projected to have the largest share of 28% in the global market in 2018. The oncology segment is mainly driven due to the increasing prevalence of cancer coupled with growing genomics research and government funding.

The genomics profile platform enables the identification of genes that are targeted by novel drugs. The drugs are developed with great sensitivity to target tumor cells. The genomics profiles enable in development of novel biomarkers which are used to diagnose disease, predict patients and respond to treatment.

Geographically, North America accounted for the largest share of the global regenerative medicine market

North America accounted for nearly 45% share of the global regenerative medicine market in 2018 and is expected to dominate the market throughout the forecast period followed by Europe and Asia-Pacific. The developed infrastructure and investment in research and development to make advanced regenerative medicine and the rising number of cancer patients are considered to be major factors that are driving the growth of the market in the North American region.

North America is one of the strongest economies globally, comprising around 23.3% of the world economy as per International Monetary Fund in 2017. According to data from OECD, in 2016 the US spent almost 17.2% of GDP on healthcare expenditure, whereas Canada spent 10.6% of GDP on healthcare. Asia-Pacific accounted for the highest CAGR in the global regenerative medicine market during the forecast period.

Company Profiles and Competitive Intelligence

The key players operating in the regenerative medicine market are:

  • Novartis International AG
  • Vericel Corporation
  • Integra LifeSciences
  • Wright Medical
  • MiMedx
  • Osiris Therapeutics
  • Stryker Corporation
  • Spark Therapeutics
  • Kite Pharma
  • Organogenesis Inc.
  • Medtronic PLC
  • Cook Biotech Incorporated
  • Amgen Inc.
  • Japan Tissue Engineering Co., Ltd.
  • Acelity L.P. Inc.
  • Becton, Dickinson and Company
  • Thermo Fisher Scientific Inc.
  • AbbVie Inc.
  • Baxter International Inc.
  • Pluristem Therapeutics Inc.

The report also provides an in-depth analysis of the global market dynamics such as drivers, restraints, opportunities, and challenges

Drivers

  • Increasing prevalence of chronic diseases and genetic diseases
  • Robust pipeline and product approval 
  • Growing government investments in regenerative medicine products

Restraints

  •  Ethical concerns related to the use of embryonic stem cells

Opportunities

  • Rising demand for organ transplantation
  • Implementation of the 21st-century cures act

Challenges

  •   Less skilled professionals

COVID-19 Impact on the Global Regenerative Medicine Market

Market Analysis

COVID-19 has highly affected the industries in terms of growth, economy, health, and mental wellbeing of every individual. In this challenging situation, every industry is trying to give the best services in terms of quality and safety. The outbreak of COVID-19 has not affected much on the healthcare industry and the regenerative medicine market. This uncertain outbreak of coronavirus has led to an increase in demand for technological advances, but the COVID 19 does not have a direct impact on the regenerative medicine market.

However, due to the outbreak of COVID- 19, the funding for the innovation in regenerative medicines distracted is the restraining factor for the growth of the global regenerative medicine market.

The report also provides an in-depth analysis of key trends in global regenerative medicine industry

  • Increasing acceptance of the regenerative medicines among the population
  • Rising expenditure on research and development activities for improving technologies related to regenerative medicine

The report also provides an in-depth analysis of recent news developments and investments

  • In March 2020, Zydus Healthcare received approval in India by national regulators to approved NASH therapy to replace the damaged liver tissues with healthier tissues.
  • In February 2020, Integra Lifesciences, launched an amniotic tissue products of allograft placental membrane and named as AmnioExcel Plus. This product is helping to repair the complex and deep wounds.

The unique insights provided by this report also includes the following:

  • In-Depth Value Chain Analysis
  • Opportunity Mapping
  • Sector Snapshot
  • Key Players Positioning Matrix
  • Regulatory Scenario
  • Strategies Adopted-Benchmarking Heat Map
  • Market Trends
  • COVID-19 Impact Analysis
  • Product Comparison
  • Pre & Post COVID 19 Impact On The Global Regenerative Medicine Market 
  • Competitive Landscape

Frequently Asked Questions (FAQs)

What is the size of global regenerative medicine market?

The global market is estimated to be USD 19.2 Bn in 2020 and is expected to reach USD 66.4 Bn by 2027.

What is the estimated market growth rate of global market?

The market is estimated to grow at a compound annual growth rate (CAGR) of 19.4% during the forecast period.

Which region accounted the largest share in global regenerative medicine market?

North America accounted for the largest share in global market.

What is the factor that hampers the growth of targeted market?

Ethical issues is the hampering factor for the growth of the targeted market.

What are the major driving factors for the growth of global market?

Increasing incidence of chronic diseases is the major driving factor for the growth of the global market.

Which is the base year provided in the report of global regenerative medicine market?

The 2020 is the base year provided in the report of global market.

Related Reports

Need specific market information ?

Ask for free product review call with the author

Share your specific research requirements for a customized report

Request for due diligence and consumer centric studies

Request for study updates, segment specific and country level reports

  1. INTRODUCTION
    1. Product Outline
    2. What is Regenerative Medicine?
    3. Different Types of Regenerative Medicine
    4. Supply Chain Analysis
    5. COVID -19 Impact
    6. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunities
      4. Threats
  2. Regulatory Landscape for Global Regenerative Medicine Market 
    1. Regulations and Standards
  3. Global Regenerative Medicine Market by Type
    1. Cell-Based Therapy & Cell Immunotherapy Products
    2. Tissue-Engineered Products
    3. Gene Therapy Products
  4. Global Regenerative Medicine Market by Applications
    1. Ocular Disorders
    2. Musculoskeletal Disorders
    3. Oncology
    4. Wound Care
    5. Diabetes
    6. Others
  5. Regional Analysis
    1. North America
      1. US
      2. Canada
      3. Mexico
    2. Europe
      1. Germany
      2. UK
      3. France
      4. Italy
      5. Spain
      6. Rest Of Europe
    3. Asia Pacific
      1. China
      2. India
      3. Japan
      4. Rest Of Asia Pacific
    4. Middle East and Africa
    5. South America
  6. Key Strategic Insights
    1. Emerging Technologies
    2. Opportunity Mapping
    3. Critical Success Factors
    4. Consumer Preferences
  7. Key Market Trends / Recent Developments
  8. Competitive Scenario
    1. Competitive Strategies of Key Players
      1. Mergers and Acquisitions
      2. Investments
      3. Joint Ventures
    2. Ranking of Key Players
  9. KEY GLOBAL PLAYERS
    1. Novartis International AG
    2. Vericel Corporation
    3. Integra LifeSciences
    4. Wright Medical
    5. MiMedx
    6. Osiris Therapeutics
    7. Stryker Corporation
    8. Spark Therapeutics
    9. Kite Pharma
    10. Organogenesis Inc.
    11. Medtronic PLC
    12. Cook Biotech Incorporated
    13. Amgen Inc.
    14. Japan Tissue Engineering Co., Ltd.
    15. Acelity L.P. Inc.

Choose License
Buy Now
Why Choose AllTheResearch?
  • Monthly market updates for 6 months
  • Online access of reports
  • Options to buy sections of report
  • Critically analysed research on “Quadrant Positioning” of your company.
  • Syndicated report along with a supplementary report with objective-based study
  • Get profiled in the reports. Expanding your visibility across our network of readers and viewers
  • We provide local market data in local language on request
  • A complementary co-branded white paper
  • Flat consulting fee based exclusive studies. Consult at the price of syndicate
  • Access to expert team for free transaction advisory service.


Quick Inquiry
Follow Us
Choose License
Buy Now